How are CVS strangle max profit and max loss calculated?

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CVS strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 26.34%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$201.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.

What is the breakeven for a CVS strangle?

The breakeven for the CVS strangle priced on this page is roughly $88.99 and $103.02 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CVS market-implied 1-standard-deviation expected move is approximately 7.55%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.

How does current CVS implied volatility affect this strangle?

CVS ATM IV is at 26.34% with IV rank near 14.84%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.

CVS Strangle Strategy

CVS (CVS Health Corporation), in the Healthcare sector, (Medical - Healthcare Plans industry), listed on NYSE.

CVS Health Corporation provides health services in the United States. The company's Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services. It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Its Pharmacy Services segment offers pharmacy benefit management solutions, including plan design and administration, formulary management, retail pharmacy network management, mail order pharmacy, specialty pharmacy and infusion, clinical, and disease and medical spend management services. It serves employers, insurance companies, unions, government employee groups, health plans, prescription drug plans, Medicaid managed care plans, plans offered on public health insurance and private health insurance exchanges, other sponsors of health benefit plans, and individuals. This segment operates retail specialty pharmacy stores; and specialty mail-order, mail-order dispensing, and compounding pharmacies, as well as branches for infusion and enteral nutrition services.

CVS (CVS Health Corporation) trades in the Healthcare sector, specifically Medical - Healthcare Plans, with a market capitalization of approximately $125.18B, a trailing P/E of 42.60, a beta of 0.59 versus the broader market, a 52-week range of 58.35-98.22, average daily share volume of 9.2M, a public-listing history dating back to 1996, approximately 300K full-time employees. These structural characteristics shape how CVS stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.59 indicates CVS has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure. The trailing P/E of 42.60 is on the rich side, which tends to correlate with higher earnings-window IV expansion as the market debates whether forward growth supports the multiple. CVS pays a dividend, which adjusts put-call parity and shifts the ex-dividend pricing across the listed chain.

What is a strangle on CVS?

A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money.

Current CVS snapshot

As of May 15, 2026, spot at $96.24, ATM IV 26.34%, IV rank 14.84%, expected move 7.55%. The strangle on CVS below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 28-day expiry.

Why this strangle structure on CVS specifically: CVS IV at 26.34% is on the cheap side of its 1-year range, which favors premium-buying structures like a CVS strangle, with a market-implied 1-standard-deviation move of approximately 7.55% (roughly $7.27 on the underlying). The 28-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CVS expiries trade a higher absolute premium for lower per-day decay. Position sizing on CVS should anchor to the underlying notional of $96.24 per share and to the trader's directional view on CVS stock.

CVS strangle setup

The CVS strangle below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CVS near $96.24, the first option leg uses a $101.00 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CVS chain at a 28-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CVS shares for the stock leg in covered calls and collars).

Action	Type	Strike / Basis	Premium (est)
Buy 1	Call	$101.00	$1.13
Buy 1	Put	$91.00	$0.89

CVS strangle risk and reward

Net Premium / Debit: -$201.50
Max Profit (per contract): Unbounded
Max Loss (per contract): -$201.50
Breakeven(s): $88.99, $103.02
Risk / Reward Ratio: Unbounded

Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit.

CVS strangle payoff curve

Modeled P&L at expiration across a range of underlying prices for the strangle on CVS. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

Underlying Price	% From Spot	P&L at Expiration
$0.01	-100.0%	+$8,897.50
$21.29	-77.9%	+$6,769.69
$42.57	-55.8%	+$4,641.88
$63.84	-33.7%	+$2,514.07
$85.12	-11.6%	+$386.26
$106.40	+10.6%	+$338.55
$127.68	+32.7%	+$2,466.35
$148.96	+54.8%	+$4,594.16
$170.23	+76.9%	+$6,721.97
$191.51	+99.0%	+$8,849.78

When traders use strangle on CVS

Strangles on CVS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CVS chain.

CVS thesis for this strangle

The market-implied 1-standard-deviation range for CVS extends from approximately $88.97 on the downside to $103.51 on the upside. A CVS long strangle is the OTM cousin of the straddle: lower up-front cost but the underlying has to travel further past either OTM strike before the position turns profitable at expiration. Current CVS IV rank near 14.84% sits in the lower third of its 1-year distribution, where IV often re-expands toward the mean; this favors premium-buying structures and disadvantages premium-selling structures on CVS at 26.34%. As a Healthcare name, CVS options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CVS-specific events.

CVS strangle positions are structurally neutral / high-volatility (long premium, OTM); the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CVS positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CVS alongside the broader basket even when CVS-specific fundamentals are unchanged. Always rebuild the position from current CVS chain quotes before placing a trade.

Frequently asked questions

What is a strangle on CVS?: A strangle on CVS is the strangle strategy applied to CVS (stock). The strategy is structurally neutral / high-volatility (long premium, OTM): A long strangle buys an OTM call and an OTM put at offset strikes, cheaper than a straddle but requiring a larger underlying move to profit since both wings start out-of-the-money. With CVS stock trading near $96.24, the strikes shown on this page are snapped to the nearest listed CVS chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are CVS strangle max profit and max loss calculated?: Upside max profit is unbounded; downside max profit is bounded at the put strike minus the combined debit (reached at zero). Max loss equals the combined debit times 100 (reached anywhere between the two OTM strikes). Two breakevens at call-strike plus debit and put-strike minus debit. For the CVS strangle priced from the end-of-day chain at a 30-day expiry (ATM IV 26.34%), the computed maximum profit is unbounded per contract and the computed maximum loss is -$201.50 per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CVS strangle?: The breakeven for the CVS strangle priced on this page is roughly $88.99 and $103.02 at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CVS market-implied 1-standard-deviation expected move is approximately 7.55%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a strangle on CVS?: Strangles on CVS are the cheaper cousin of the straddle - traders use them when they want a large directional move but are willing to give up the inner-strike sensitivity in exchange for a lower up-front debit on the CVS chain.
How does current CVS implied volatility affect this strangle?: CVS ATM IV is at 26.34% with IV rank near 14.84%, which is on the low end of its 1-year range. Premium-buying structures (long call, long put, debit spreads) are relatively cheap in this regime; premium-selling structures collect less credit per unit risk.